Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9601 USD | -2.53% | -7.68% | -10.27% |
May. 14 | Transcript : MiNK Therapeutics, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | MiNK Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 34.18M |
---|---|---|---|---|---|
Net income 2024 * | -39M | Net income 2025 * | -36M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.49
x | P/E ratio 2025 * |
-1.48
x | Employees | 31 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 37.17% |
Latest transcript on MiNK Therapeutics, Inc.
1 day | -2.53% | ||
1 week | -7.68% | ||
Current month | -3.02% | ||
1 month | +10.23% | ||
3 months | +6.68% | ||
6 months | -8.56% | ||
Current year | -10.27% |
Managers | Title | Age | Since |
---|---|---|---|
Jennifer Buell
CEO | Chief Executive Officer | 50 | 21-01-31 |
Heather Boussios
CMP | Compliance Officer | - | - |
Marc van Dijk
CTO | Chief Tech/Sci/R&D Officer | 61 | 20-02-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Garo Armen
CHM | Chairman | 71 | 17-06-30 |
Director/Board Member | 66 | 17-06-30 | |
Barbara Ryan
BRD | Director/Board Member | 64 | 21-08-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 0.9601 | -2.53% | 44,798 |
24-05-23 | 0.985 | -1.50% | 92,406 |
24-05-22 | 1 | +1.01% | 87,901 |
24-05-21 | 0.99 | -1.98% | 33,800 |
24-05-20 | 1.01 | 0.00% | 28,388 |
Delayed Quote Nasdaq, May 24, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.27% | 34.18M | |
+67.53% | 62.86B | |
-0.77% | 41.38B | |
+45.66% | 40.38B | |
-10.72% | 27.64B | |
+13.30% | 26.46B | |
-22.79% | 18.9B | |
+4.70% | 12.67B | |
+24.10% | 12.27B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- INKT Stock